Examkin

Question

Difficulty: MediumEnd-of-Life and Palliative Care

Match each clinical presentation in the palliative care setting with the most appropriate next step in management.

  • A 72-year-old woman with end-stage chronic obstructive pulmonary disease who experiences severe, unrelenting breathlessness at rest despite maximal inhaler therapy.Initiation of low-dose oral opioids
  • A 55-year-old man with metastatic pancreatic cancer who develops generalized myoclonus, hallucinations, and hyperalgesia after a recent dose increase of oral morphine.Opioid rotation and intravenous hydration
  • A 64-year-old woman with metastatic breast cancer to the spine who reports severe, localized, aching pain in her mid-back that worsens with movement.Referral for palliative external beam radiation therapy
  • A 79-year-old man with terminal lung cancer and multi-organ failure who exhibits severe, intractable agitation and distress in his final hours despite administration of haloperidol and opioids.Initiation of palliative sedation with an intravenous benzodiazepine

Answer

The COPD patient requires low-dose oral opioids; the patient with opioid-induced neurotoxicity requires opioid rotation and intravenous hydration; the patient with localized metastatic bone pain requires referral for palliative external beam radiation therapy; and the patient with terminal delirium requires initiation of palliative sedation with an intravenous benzodiazepine.
Each clinical scenario requires a specific, distinct palliative intervention. Refractory dyspnea in advanced COPD is treated with low-dose systemic opioids to reduce the central respiratory drive and the sensation of breathlessness. Opioid-induced neurotoxicity, presenting as myoclonus and hyperalgesia, is managed by clearing active metabolites with hydration and rotating to a different opioid to avoid cross-tolerance. Severe, localized pain from metastatic bone disease is highly responsive to palliative external beam radiation therapy. Lastly, when a patient in the final hours of life experiences intractable agitation that does not respond to standard treatments, palliative sedation (often with a benzodiazepine like midazolam) is ethically and clinically indicated to relieve suffering.

Step-by-Step Solution

1
Identify the primary distressing symptom and underlying clinical context for each patient.
Patient 1 has refractory dyspnea; Patient 2 has opioid-induced neurotoxicity; Patient 3 has localized metastatic bone pain; Patient 4 has refractory terminal delirium.
Accurate characterization of distinct palliative symptom syndromes dictates the choice of targeted therapy.
2
Determine the evidence-based standard of care for each identified symptom presentation.
Dyspnea is managed with opioids. Opioid neurotoxicity requires rotation and hydration. Localized bone pain responds to radiation. Refractory terminal agitation requires palliative sedation.
Applying standard palliative care protocols ensures effective symptom control and avoids common pharmacological errors.

Key Concept

Targeted symptom management in end-of-life care
Rate this question

Topics

End-of-Life and Palliative Care

More questions from this topic